The impact of chronic liver disease on the risk assessment of ACS NSQIP morbidity and mortality after hepatic resection
作者: Victor M. ZaydfudimMatthew J. KerwinFlorence E. TurrentineTodd W. BauerReid B. AdamsGeorge J. Stukenborg
作者单位: 1Section of Hepatobiliary and Pancreatic Surgery, Department of Surgery, University of Virginia, Charlottesville, VA
2Surgical Outcomes Research Center, University of Virginia, Charlottesville, VA
3Department of Surgery, University of Virginia, Charlottesville, VA
4Division of Patient Outcomes, Policy & Population Research, University of Virginia, Charlottesville, VA
刊名: Surgery, 2016, Vol.159 (5), pp.1308-1315
来源数据库: Elsevier Journal
DOI: 10.1016/j.surg.2015.11.020
英文摘要: Background(#br)The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) risk-adjustment model for patients who require hepatic resection does not include metrics of underlying chronic liver disease. The applicability of the current risk adjustment model is under debate. This study aims to assess the impact of chronic liver disease on the ACS NSQIP estimates of postoperative morbidity and mortality.(#br)Study design(#br)This retrospective cohort study included all cases of hepatic resection at our quaternary referral institution between 2006 and 2013. Metrics of chronic liver disease were abstracted and linked with the ACS NSQIP risk-adjustment model estimated probabilities of morbidity and mortality for each case. Sequential general linear models were...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:3.373 (2012)

×